Skip to main content
Journal cover image

New methods facilitated the process of prioritizing questions and health outcomes in guideline development.

Publication ,  Journal Article
Wiercioch, W; Nieuwlaat, R; Zhang, Y; Alonso-Coello, P; Dahm, P; Iorio, A; Manja, V; Mustafa, RA; Neumann, I; Ortel, TL; Rochwerg, B; Akl, EA ...
Published in: J Clin Epidemiol
March 2022

BACKGROUND: Health guideline development requires sequential prioritization of the guideline topic, questions, and health outcomes. In this paper we report on new approaches for prioritizing questions and outcomes in guidelines. METHODS: Ten guideline panels on venous thromboembolism rated potential guideline questions on a 9-point scale according to their overall importance and 6 criteria: common in practice, uncertainty in practice, variation in practice, new evidence available, cost consequences, not previously addressed. We randomized panelists to rate one potential question with and without the 6 criteria. Panelists rated importance of outcomes, defined with health outcome descriptors (HODs), using a 9-point scale, and health utility of outcomes on a visual analogue scale. RESULTS: Of 469 potential questions identified, 72.5% were rated as important but not of high priority, and 25.4% as high priority. Each criterion was significantly associated with the overall importance rating. The overall importance rating means were 5.96 (SD 2.38) and 6.53 (SD 2.45) (P = 0.25) for those randomized to rate questions with and without the criteria, respectively. The mean importance rating for 121 outcomes was 6.01 (SD 1.25), with 35.5% rated as critical for decision-making. Panelists provided health utility ratings for 127 outcomes, with a minimum mean rating of 0.12 (SD 0.10) and maximum of 0.91 (SD 0.15). CONCLUSION: Our structured process provided information to help explain perspectives of question importance, to facilitate panels' outcome prioritization, and to facilitate decision-making in guideline development.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Epidemiol

DOI

EISSN

1878-5921

Publication Date

March 2022

Volume

143

Start / End Page

91 / 104

Location

United States

Related Subject Headings

  • Venous Thromboembolism
  • Outcome Assessment, Health Care
  • Humans
  • Epidemiology
  • 4202 Epidemiology
  • 11 Medical and Health Sciences
  • 01 Mathematical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wiercioch, W., Nieuwlaat, R., Zhang, Y., Alonso-Coello, P., Dahm, P., Iorio, A., … Schünemann, H. J. (2022). New methods facilitated the process of prioritizing questions and health outcomes in guideline development. J Clin Epidemiol, 143, 91–104. https://doi.org/10.1016/j.jclinepi.2021.11.031
Wiercioch, Wojtek, Robby Nieuwlaat, Yuan Zhang, Pablo Alonso-Coello, Philipp Dahm, Alfonso Iorio, Veena Manja, et al. “New methods facilitated the process of prioritizing questions and health outcomes in guideline development.J Clin Epidemiol 143 (March 2022): 91–104. https://doi.org/10.1016/j.jclinepi.2021.11.031.
Wiercioch W, Nieuwlaat R, Zhang Y, Alonso-Coello P, Dahm P, Iorio A, et al. New methods facilitated the process of prioritizing questions and health outcomes in guideline development. J Clin Epidemiol. 2022 Mar;143:91–104.
Wiercioch, Wojtek, et al. “New methods facilitated the process of prioritizing questions and health outcomes in guideline development.J Clin Epidemiol, vol. 143, Mar. 2022, pp. 91–104. Pubmed, doi:10.1016/j.jclinepi.2021.11.031.
Wiercioch W, Nieuwlaat R, Zhang Y, Alonso-Coello P, Dahm P, Iorio A, Manja V, Mustafa RA, Neumann I, Ortel TL, Rochwerg B, Santesso N, Vesely SK, Akl EA, Schünemann HJ. New methods facilitated the process of prioritizing questions and health outcomes in guideline development. J Clin Epidemiol. 2022 Mar;143:91–104.
Journal cover image

Published In

J Clin Epidemiol

DOI

EISSN

1878-5921

Publication Date

March 2022

Volume

143

Start / End Page

91 / 104

Location

United States

Related Subject Headings

  • Venous Thromboembolism
  • Outcome Assessment, Health Care
  • Humans
  • Epidemiology
  • 4202 Epidemiology
  • 11 Medical and Health Sciences
  • 01 Mathematical Sciences